The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day.
Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm.
| Behavioral Health Care |
|
|
| Acquirer |
Target |
Price |
| Blue Sprig Pediatrics, Inc. |
West Texas Autism Center |
N/A |
| Pinnacle Treatment Centers |
American Addiction Treatment Center programs |
N/A |
| Biotechnology |
|
|
| Acquirer |
Target |
Price |
| Castle Creek Pharmaceuticals LLC |
Collaboration on FCX-007 |
$7,500,000 |
| Gilead Sciences, Inc. |
Collaboration on NASH therapies |
$15,000,000 |
| eHealth |
|
|
| Acquirer |
Target |
Price |
| symplr |
IntelliSoft Group |
N/A |
| EMV Capital |
Wanda, Inc. |
N/A |
| Home Health Care & Hospice |
|
|
| Acquirer |
Target |
Price |
| Air Liquide |
DiaLibre |
N/A |
| Long-Term Care |
|
|
| Acquirer |
Target |
Price |
| Target Healthcare REIT Limited |
Care home |
$9,000,000 |
| Managed Care |
|
|
| Acquirer |
Target |
Price |
| Fringe Benefit Group |
Century Healthcare, LLC |
N/A |
| Medical Devices |
|
|
| Acquirer |
Target |
Price |
| Medline Industries, Inc. |
Namic fluid management business |
$167,500,000 |
| Pharmaceuticals |
|
|
| Acquirer |
Target |
Price |
| Canopy Growth Corporation |
Canamo y Fibras Naturales, S.L. |
N/A |
| Adare Pharmaceuticals, Inc. |
Parvulet technology platform |
N/A |
| MS Pharma |
Genepharm |
N/A |
| The Ethypharm Group |
Pharmy II Laboratory |
N/A |
| Physician Medical Groups |
|
|
| Acquirer |
Target |
Price |
| Omni Ophthalmic Management Consultants |
Ludwick Eye Center |
N/A |
| Surge Private Equity |
Access Dental and Lacosta Dental |
$30,000,000 |
| Other Services |
|
|
| Acquirer |
Target |
Price |
| Catalent, Inc. |
Paragon Bioservices, Inc. |
$1,200,000,000 |
| Frazier Healthcare Partners |
Comprehensive Pharmacy Services |
N/A |
| Laboratory Corp. of America |
Envigo’s nonclinical research services business |
$485,000,000 |
